Neuronata-R retains conditional approval in South Korea
July 20, 2026 | 10:24
South Korea's Ministry of Food and Drug Safety updated its conditional approval of the stem cell therapy Neuronata-R in May 2026, as the developer works to resume supply and establish a US research base.
Mobile Version